Literature DB >> 9336935

A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa.

D van Soolingen1, T Hoogenboezem, P E de Haas, P W Hermans, M A Koedam, K S Teppema, P J Brennan, G S Besra, F Portaels, J Top, L M Schouls, J D van Embden.   

Abstract

In an attempt to characterize an unusual mycobacterial strain isolated from a 2-year-old Somali patient with lymphadenitis, we applied various molecular methods not previously used for the taxonomic classification of mycobacteria. This isolate, designated So93, did not differ from Mycobacterium tuberculosis in the biochemical tests and in its 16S rRNA sequence, but produced smooth and glossy colonies, which is highly exceptional for this species. This smooth phenotype was unstable and switched nonreversibly to a rough colony morphology with a low frequency. The two colony types were equally virulent for the guinea pig, exhibiting characteristic tuberculous disease. Both morphotypes had shorter generation times than the M. tuberculosis reference laboratory strain H37Rv and clinical isolates of M. tuberculosis and Mycobacterium bovis. Furthermore, the So93 isolate differed from all M. tuberculosis complex strains described thus far by having only a single copy of insertion sequence IS1081, an unusual composition of the direct repeat cluster, and a characteristic phenolic glycolipid and lipooligosaccharide. This glycolipid had previously been observed only in a smooth isolate of M. tuberculosis obtained in 1969 by Canetti in France. Analysis of the Canetti strain showed that it shared virtually all genetic properties characteristic of So93, distinguishing these two strains from the known M. tuberculosis complex taxa, M. tuberculosis, Mycobacterium africanum, M. bovis, and Mycobacterium microti. The natural reservoir, host range, and mode of transmission of the group of bacteria described in this paper are presently unknown. This study, partly based on not previously used molecular criteria, supports the idea that the established members within the M. tuberculosis complex and the newly described Canetti grouping should be regarded as a single species, which likely will be designated "M. tuberculosis".

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9336935     DOI: 10.1099/00207713-47-4-1236

Source DB:  PubMed          Journal:  Int J Syst Bacteriol        ISSN: 0020-7713


  104 in total

1.  High genetic diversity revealed by variable-number tandem repeat genotyping and analysis of hsp65 gene polymorphism in a large collection of "Mycobacterium canettii" strains indicates that the M. tuberculosis complex is a recently emerged clone of "M. canettii".

Authors:  Michel Fabre; Jean-Louis Koeck; Philippe Le Flèche; Fabrice Simon; Vincent Hervé; Gilles Vergnaud; Christine Pourcel
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

2.  First worldwide proficiency study on variable-number tandem-repeat typing of Mycobacterium tuberculosis complex strains.

Authors:  Jessica L de Beer; Kristin Kremer; Csaba Ködmön; Philip Supply; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

3.  Evaluation of the GenoType MTBC assay for differentiating 120 clinical Mycobacterium tuberculosis complex isolates.

Authors:  I K Neonakis; Z Gitti; E Petinaki; S Maraki; D A Spandidos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

4.  pks5-recombination-mediated surface remodelling in Mycobacterium tuberculosis emergence.

Authors:  Eva C Boritsch; Wafa Frigui; Alessandro Cascioferro; Wladimir Malaga; Gilles Etienne; Françoise Laval; Alexandre Pawlik; Fabien Le Chevalier; Mickael Orgeur; Laurence Ma; Christiane Bouchier; Timothy P Stinear; Philip Supply; Laleh Majlessi; Mamadou Daffé; Christophe Guilhot; Roland Brosch
Journal:  Nat Microbiol       Date:  2016-01-27       Impact factor: 17.745

5.  Key experimental evidence of chromosomal DNA transfer among selected tuberculosis-causing mycobacteria.

Authors:  Eva C Boritsch; Varun Khanna; Alexandre Pawlik; Nadine Honoré; Victor H Navas; Laurence Ma; Christiane Bouchier; Torsten Seemann; Philip Supply; Timothy P Stinear; Roland Brosch
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-15       Impact factor: 11.205

6.  Mycobacterium bovis subsp. caprae caused one-third of human M. bovis-associated tuberculosis cases reported in Germany between 1999 and 2001.

Authors:  Tanja Kubica; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model.

Authors:  J Dormans; M Burger; D Aguilar; R Hernandez-Pando; K Kremer; P Roholl; S M Arend; D van Soolingen
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

8.  Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for routine identification of Mycobacterium species isolated from clinical sources.

Authors:  Alan McNabb; Diane Eisler; Kathy Adie; Marie Amos; Mabel Rodrigues; Gwen Stephens; William A Black; Judith Isaac-Renton
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  Mycobacterium microti infection (vole tuberculosis) in wild rodent populations.

Authors:  Rachel Cavanagh; Michael Begon; Malcolm Bennett; Torbjørn Ergon; Isla M Graham; Petra E W De Haas; C A Hart; Marianne Koedam; Kristin Kremer; Xavier Lambin; Paul Roholl; Dick van Soolingen Dv
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda.

Authors:  S Niemann; S Rüsch-Gerdes; M L Joloba; C C Whalen; D Guwatudde; J J Ellner; K Eisenach; N Fumokong; J L Johnson; T Aisu; R D Mugerwa; A Okwera; S K Schwander
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.